These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10715016)

  • 1. Disruption of the Borrelia burgdorferi gac gene, encoding the naturally synthesized GyrA C-terminal domain.
    Knight SW; Kimmel BJ; Eggers CH; Samuels DS
    J Bacteriol; 2000 Apr; 182(7):2048-51. PubMed ID: 10715016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.
    Samuels DS; Mach KE; Garon CF
    J Bacteriol; 1994 Oct; 176(19):6045-9. PubMed ID: 7928965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
    Samuels DS; Marconi RT; Huang WM; Garon CF
    J Bacteriol; 1994 May; 176(10):3072-5. PubMed ID: 8188609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural synthesis of a DNA-binding protein from the C-terminal domain of DNA gyrase A in Borrelia burgdorferi.
    Knight SW; Samuels DS
    EMBO J; 1999 Sep; 18(17):4875-81. PubMed ID: 10469665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient targeted mutagenesis in Borrelia burgdorferi.
    Bono JL; Elias AF; Kupko JJ; Stevenson B; Tilly K; Rosa P
    J Bacteriol; 2000 May; 182(9):2445-52. PubMed ID: 10762244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.
    Rosa P; Samuels DS; Hogan D; Stevenson B; Casjens S; Tilly K
    J Bacteriol; 1996 Oct; 178(20):5946-53. PubMed ID: 8830691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B; Hooper DC
    Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
    Contreras A; Maxwell A
    Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
    Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the NH2-terminal 83rd amino acid of Escherichia coli GyrA in quinolone-resistance.
    Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H
    Microbiol Immunol; 1995; 39(4):243-7. PubMed ID: 7651238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A
    Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
    Samuels DS; Garon CF
    Antimicrob Agents Chemother; 1993 Jan; 37(1):46-50. PubMed ID: 8381639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide-mediated genetic transformation of Borrelia burgdorferi.
    Samuels DS; Garon CF
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():519-522. PubMed ID: 9043127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A; Diver JM; Beckthold B; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniae.
    Balas D; Fernández-Moreira E; De La Campa AG
    J Bacteriol; 1998 Jun; 180(11):2854-61. PubMed ID: 9603872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase.
    Onodera Y; Sato K
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2423-9. PubMed ID: 10508019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relapsing fever spirochete Borrelia hermsii contains multiple, antigen-encoding circular plasmids that are homologous to the cp32 plasmids of Lyme disease spirochetes.
    Stevenson B; Porcella SF; Oie KL; Fitzpatrick CA; Raffel SJ; Lubke L; Schrumpf ME; Schwan TG
    Infect Immun; 2000 Jul; 68(7):3900-8. PubMed ID: 10858201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.